Description :alizapride is a dopamine antagonist with prokinetic and antiemetic effectsindication : used in the treatment of nausea and vomiting, including postoperative nausea and vomiting.mechanism of action :the anti-emetic action of alizapride is due to its antagonist activity at d2 receptors in the chemoreceptor trigger zone (ctz) in the central nervous system (cns)
this action prevents nausea and vomiting triggered by most stimuli. structurally similar to metoclopramide and, therefore, shares similar other atributres related to emesis and prokinetics.half life :3 hours